$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

프리바이오틱스의 기능에 관한 연구 고찰
Prebiotics: A Review 원문보기

한국식품영양학회지 = The Korean journal of food and nutrition, v.30 no.2, 2017년, pp.191 - 202  

윤진아 (케이씨대학교 식품과학부) ,  신경옥 (삼육대학교 식품영양학과)

Abstract AI-Helper 아이콘AI-Helper

This study was conducted to investigate the characteristics of major prebiotics and the related studies, and to provide basic data for future research. Prebiotics are defined as 'nondigestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or activity of...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

문제 정의

  • 잘 알려진 프리바이오틱스로는 이눌린(inulin), 올리고프락토오스(oligofructose), 갈락토-올리고당(galacto-oligosaccharide), 갈락토프락토오스(galactofructose) 등이 있으며, 이들은 고유의 물리화학적 특성과 더불어 유산균의 기질로 작용하여 유산균의 활동을 도움으로써 건강에 도움을 준다. 본 연구는 현재까지 알려진 주요 프리바이오틱스의 특성과 관련 연구에 대해 고찰함으로써 향후 연구에 대한 기초 자료를 제공하기 위해 수행되었다.
본문요약 정보가 도움이 되었나요?

질의응답

핵심어 질문 논문에서 추출한 답변
갈락토-올리고당은 당 분자가 어떤 결합을 하였는가? 갈락토-올리고당은 당 분자가 β-glycosidic 결합을 한 중합체를 의미한다. 말단에는 포도당이 결합되어 있다(BrunoBarcena & Azcarate-Peril 2015).
갈락토-올리고당의 말단에는 무엇이 결합되어 있는가? 갈락토-올리고당은 당 분자가 β-glycosidic 결합을 한 중합체를 의미한다. 말단에는 포도당이 결합되어 있다(BrunoBarcena & Azcarate-Peril 2015). GOS는 모유의 올리고당과 유사하며, 장내 미생물에 미치는 영향도 흡사하다(Boehm & Stahl 2003).
프리바이오틱스는 무엇인가? 이러한 추세에 따라 부각되기 시작한 것 중 하나가 프리바이오틱스이다. Gibson & Roberfroid (1995)는 연구에서 프리바이오틱스를 “대장에서 하나 또는 제한된 몇몇 세균의 성장과 활동을 선택적으로 자극하여 건강을 개선함으로써 숙주에게 유익을 주는 비소화성 식품 성분”이라고 최초로 정의하였으며, 시대의 흐름에 따라 몇차례 재정의되기는 하였으나(Reid 등 2003; Gibson 등 2004; Pineiro 등 2008; Gibson 등 2010), 큰 틀은 유지되고 있다(Hukins 등 2016). 잘 알려진 프리바이오틱스로는 이눌린(inulin), 올리고프락토오스(oligofructose), 갈락토-올리고당(galacto-oligosaccharide), 갈락토프락토오스(galactofructose) 등이 있으며, 이들은 고유의 물리화학적 특성과 더불어 유산균의 기질로 작용하여 유산균의 활동을 도움으로써 건강에 도움을 준다.
질의응답 정보가 도움이 되었나요?

참고문헌 (140)

  1. Abrams SA, Griffin IJ, Hawthorne KM, Ellis KJ. 2007a. Effects of prebiotic supplementation and calcium intake on body mass index. J Pediatrics 151:293-298 

  2. Abrams SA, Hawthorne KM, Aliu O, Hicks PD, Chen Z, Griffin IJ. 2007b. An inulin-tye fructan enhances calcium absorption primarily via an effect on colonic absorption in humans. J Nutr 137:2208-2212 

  3. Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. 2008. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 138:1091-1095 

  4. Ballongue J, Schumann C, Quignon P. 1997. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scandinavian J Gastroenterol 32:41-44 

  5. Bang MH, Chio OS, Kim WK. 2007. Soyoligosaccharide increases faecal bifidobacteria ounts, short chain fatty acids and faecal lipid concentrations in young Korean women. J Med Food 10:366-370 

  6. Bartman HP, Scheppach W, Gerlach S, Ruckdeschel G, Kelber E, Kasper H. 1994. Does yogurt enriched with Bifidobacterium longum affect colonic microbiology and fecal metabolites in health subjects? Am J Clin Nutr 59:428-432 

  7. Bass P, Dennis. 1981. The laxative effects of lactulose in normal and constipated subjects. J Clin Gastroenterol 3:23-28 

  8. Battermann W. 1997. Latulose powder-main technological properties and its relevance in fuctional food. Intl Rep Solvay Deutschland GmbH 12:41-97 

  9. Benno Y, Endo K, Shiragami N, Sayama K, Mitsuoka T. 1987. Effects of raffinose intake on human faecal microflora. Bifidobacteria Microflora 6:59-63 

  10. Bharti SK, Krishnan S, Kumar A, Gupta AK, Ghosh AK, Kumar A. 2015. Mechanism-based antidiabetic activity of fructoand isomalto-oligosaccharides: Validation by in vivo, in silico and in vitro interaction potential. Process Biochem 50:317-327 

  11. Bianchi GP, De Mitri MS, Eugianesi E, Abbiati R, Fabbri A, Marchesini G. 1994. Lowering effects of a preparation containing fibres and lactulose on glucose and insulin levels in obesity. Ital J Gastroenterol 26:174-178 

  12. Boehm G, Stahl B. 2003. Oligosaccharides, in Functional Dairy Products. Cambridge, England, Woodhead Publishing Limited. pp.203-243 

  13. Boehm G, Stahl B, Jelinek J, Knal J, Miniello V, Moro GE. 2005. Prebiotic carbohydrate in human milk and formulas. Acta Paediatrica Suppl 94:18-21 

  14. Bosscher D, Van Loo J, Franck A. 2006. Inulin and oligofructose as prebiotics in the prevention of intestinal infections and diseases. Nutr Res Rev 19:216-226 

  15. Bouhnik Y, Raskine L, Champion K, Andrieux C, Penven S, Jacobs H, Simoneau G. 2007. Prolonged administration of low-dose inulin stimulates the growth of bifidobacteria in humans. Nutr Res 27:187-193 

  16. Bruno-Barcena JM, Andrea Azcarate-Peril M. 2015. Galactooligosaccharides and colorectal cancer: Feeding our intestinal probiome. J Functional Food 12:92-108 

  17. Campbell JM, Fahey GC, Wolf BW. 1997. Selected indigestible oligosaccharides affect large bowel mass, cecal and faecal short-chain fatty acid, pH and microflora in rats. J Nutr 127:130-136 

  18. Carobbi R, Innocenti F. 1990. Process for preparing lactulose from lactose by epimerization with sodium aluminate. Eu Patent 0320670 

  19. Chandan RC, Shah NP. 2007. Functional foods based on dairy ingredients. In Handbook of Food Products Manufacturingprinciples, Bakery, Beverage, Cereals, Cheese, Confectionary, Fats, Fruits, and Functional Foods. Hoboken, NJ: John Wiley & Sons. pp.971-987 

  20. Chen J, Liang R, Liu W, Li T, Liu C, Wu S, Wang Z. 2013. Pectic-oligosaccharides prepared by dynamic high-pressure microfluidization and their in vitro fermentation properties. Carbohydrate Polymer 91:175-182 

  21. Chen HL, Lu YH, Lin JJ, Ko LY. 2001. Effects of isomaltooligosaccharides on bowel functions and indicators of nutritional status in constipated elderly men. J Am College Nutr 20:44-49 

  22. Chonan O, Watanuki M. 1996. The effect of 6'-galactooligosaccharides on bone mineralization of rats adapted to different levels of dietary calcium. Intl J Vit Nutr Res 66:244-249 

  23. Coopa GV, Bruni S, Morelli L, Soldi S, Gabrielli O. 2004. The first prebiotics in human: human milk oligosaccharides. J Clin Gastroenterol 38:S80-S83 

  24. Coxam V. 2005. Inulin-type fructans and bone health: state of the art and perspectives in the management of osteoporosis. Brit J Nutr 93:S111-S123 

  25. Crittenden RG, Playne MJ. 1996. Production, properties and application of food-grade oligosaccharides. Trends Food Sci Technol 7:353-61 

  26. De Leenheer L. 1996. Production and Use of Inulin: Industrial Reality with a Promising Future, in Carbohydrates as Organic Raw Materials III, VCH Publ. Inc., New York. pp.67-92 

  27. De Leenheer L, Hoebregs H. 1994. Progress in the elucidation of the composition of chicory inulin. Starch 46:193-196 

  28. Delzenne NM, Kok N, Fiordaliso MF, Deboyser DM, Goethals FM, Roberfroid MB. 1993. Dietary fructoologosaccharides modify lipid metabolism in rats. Am J Clin Nutr 57:820S 

  29. De Vuyst L, Moens F, Selak M, Riviere A, Leroy F. 2014. Summer Meeting 2013: growth and physiology of bifidobacteria. J Appl Microbiol 116:477-491 

  30. Djouzi Z, Andrieux C, Pelenc V, Somarriba S, Popot F, Paul F, Monsan P, Szylit O. 1995. Degradation and fermentation of alpha-gluco-oligosaccharides by bacterial strains from human colon: in vitro and in vivo studies in gnotobiotic rats. J Appl Bacteriol 79:117-27 

  31. Dorotea LM, Maris DNM. 2005. Molecular properties and prebiotic effect of inulin obtained from artichoke (Cynara scolymus L.). Phytochemistry 66:1476-1484 

  32. Ferchaud-Roucher V, Pouteau E, Piloquet E, Zair Y, Krempf M. 2005. Colonic fermentation from lactulose inhibits lipolysis in overweight subjects. Am J Physiol Endocrinol Metabol 289:E716-E720 

  33. Fiordaliso M, Kok N, Desager JP, Goethals F, Deboyser D, Roberfroid M, Delzenne N. 1995. Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats. Lipids 30:163-167 

  34. Genovese S, Riccardi G, Rivellese AA. 1993. Lactulose improves blood glucose response to an oral glucose test in non-insulin dependent diabetic patients. Diabetes Nutr Metabol 5:295-297 

  35. Gibson GR, Probert HM, Loo JV, Rasrall RA, Roberfroid MB. 2004. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17:259-275 

  36. Gibson GR, Roberfroid MB. 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:1401-1412 

  37. Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert-Ferrandon A, Garau M, Murphy EF, Saulnier D, Loh G, Macfarlane S, Dezenne N, Ringel Y, Kozianowski G, Dickmann R, Lenoir-Wijnwook I, Walker C, Buddington R. 2010. Dietary prebiotics: current status and new definition. Food Sci Technol Bull: Funct Foods 7:1-19 

  38. Gomez B, Gullon B, Remoroza C, Schols HA, Parajo JC, Alonso JL. 2014. Purification, characterization, and prebiotic properties of pectic oligosaccharides from orange peel wastes. J Agric Food Chem 62:9769-9782 

  39. Gomez B, Gullon B, Yanez R, Schols H, Alonso JL. 2016. Prebiotic potential of pectins and pectic oligosaccharides derived from lemon peel wastes and sugar beet pulp: A comparative evaluation. J Func Foods 20:108-121 

  40. Gostner A, Schaffer V, Theis S, Menzel T, Lujrs H, Melcher R, Schauber J, Kulich T, Dusel G, Dorbath D, Kozianowski G, Scheppach W. 2005. Effects of isomalt consumption on gastrointestinal and metabolic parameters in healthy volunteers. Brit J Nutr 95:40-50 

  41. Goulas AK, Fisher DA, Grimble GK, Grandison AS, Rastall RA. 2004. Synthesis of isomalto-oligosaccharides and oligodextrans by the combined use of dextransucrase and dextranase. Enzyme and Microbial Technol 35:327-328 

  42. Greve JWN, Gouma DJ, von Leeuwen PA, Buurman WA. 1990. Lactulose inhibits endotoxin-induced tuour necrosis factor production by monocytes. An in vitro study. Gut 31:198-203 

  43. Guerrero C, Wilson L. 2016. Ch 5-Enzymatic Production of Lactulose, in Lactose-Derived Prebiotics: A Process Perspective. Academic Press. pp.191-227 

  44. Gyorgy P, Norris RF, Rose SR. 1954. Bifidus factor. I. A varianf of Lactobacillus bifidus requiring a special growth factor. Arch Biochem Biophys 43:193-201 

  45. Hara T, Ikeda N, Hatsumi K, Watabe J, Lino H, Mitsuoka T. 1997. Effects of small amount ingestion of soybean oligosaccharides on bowel habits and faecal flora of volunteers. Japanese J Nutr 55:79-84 

  46. Hayakawa K, Mizutani J, Wada K, Masai T, Yoshihara I. Mitsuoka T. 1990. Effects of soybean oligosaccharides on human faecal flora. Microbial Ecol Health Dis 3:293-303 

  47. Hegazi RA, Seth A. 2013. The role of prebiotics in gastrointestinal and liver diseases, in Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. Academic press, London, UK. pp.569-583 

  48. Hidaka M, Tashiro Y, Eida T. 1991. Proliferation of bifidobacteria by oligosaccharides and their useful effect on human health. Bifidobact Microflora 10:65-79 

  49. Hotchkiss Jr AT, Olano-Martin E, William EG, Gibson GR, Rastall RA. 2003. Pectic oligosaccharides as prebiotics. ACS Symposium Series (Oligosaccharides in Food and Agriculture) 849:54-62 

  50. Hughes SA, Shewry PR, Li L, Gibson GR, Sanz ML, Rastall RA. 2007. In vitro fermentation by human faecal microflora of wheat arabinoxylans. J Agric Food Chem 55:4589-4595 

  51. Hukins RW, Krumbeck JA, Bindels LB, Cani PD, Fahey Jr. G, Goh YJ, Hamaker B, Martens EC, Mills DA, Rastal RA, Vaughan E, Sanders ME. 2016. Prebiotics: why definition matter. Curr Opin Biotechnol 37:1-7 

  52. Kishino E, Norii M, Fusita K, Hara K, Teramoto F, Fukunaga M. 2006. Enhancement by lactosucrose of the calcium absorption from the intestine in growing rats. Biosci Biotech Biochem 70:1485-1488 

  53. Knol J, Boehm G, Lidestri M, Negretti F, Jelinek J, Agosti M, Stahl B, Marini A, Mosca F. 2005. Increase of fecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formulafed preterm infants. Acta Paediatrica 94:31-33 

  54. Kohmoto T, Fukui F, Takaka H, Machida Y, Arai M, Mitsuoka T. 1988. Effect of isomalto-oligosaccharides on human fecal flora. Bifidobacteria Microflora 7:61-69 

  55. Kok N, Morgan LM, Williams CM, Roberfroid MB, Thissen JP, Delzenne M. 1998. Insulin, glucagon-like peptide 1, glucosedependent insulinotrotpic polypeptide and insulin-like growth factor I as putative mediators of the hypolipidemic effect of oligofructose in rats. J Nutr 128:1099-1103 

  56. Kontula P, von Wright A, Mattila-Sandholm T. 1998. Oat bran ${\beta}$ -gluco- and xylo-oligosaccharides as fermentative substrates for lactic acid bacteria. Intl J Food Microbiol 45:163-169 

  57. Kothari D, Goyal A. 2015. Gentio-oligosaccharides from Leuconostoc mesenteroides NRRL B-1426 dextransucrase as prebiotics and as a supplement for functional foods with anti-cancer properties. Food Funct 6:604-611 

  58. Krumbbloz RE, Dorscheid MG. 1991. Method of manufacturing lactulose. Eu patent 0375040 

  59. Kumemura M, Hashimoto F, Fujii F, matsuo K, Kimura H, Miyazoe R, Okamatsu H, Inokuchi T, Ito H, Oizumi K, Oku T. 1992. Effects of administration of 4g- ${\beta}$ -D-galactosylsucrose on faecal microflora, putrefactive products, short chain fatty acids, weight, moisture and pH and the subjective sensation of defecation in the elderly constipation. J Clin Nutr 13: 199-210 

  60. Kunz C, Rudloff S, Baier W, Klien N, Strobel S. 2000. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Ann Rev Nutr 20:699-722 

  61. Leach JD, Gibson GR, Van loo J. 2006. Human evolution, nutritional ecology and prebiotics in ancient diet. Biosci Microflora 25:1-8 

  62. Liehr H, Englisch G, Rasenack U. 1981. Treatment of endotoxeia in galactosamine hepatitis by lactulose administered intravenously. Hepatogastroenterology 28:296-298 

  63. Lobo AR, Colli C, Filisetti TMCC. 2006. Fructooligosaccharides improve bone mass and biochemical properties in rats. Eu J Nutr 42:91-98 

  64. Macfarlane GT, Steeds H, Macfarlane S. 2008. Bacterial metabolism and health related effects of galactooligosaccharides and other prebiotics. J Appl Microbiol 104:305-344 

  65. MacGillivray PC, Finaly HV, Binns Tb. 1959. Use of lactulose to create a preponderance of lactobailli in the intestine of bottle-fed infants. Scottish Med J 4:182-189 

  66. Martinez-Villaluenga C, Cardelle-Cobas A, Corzo N, Olano A, Villamiel M. 2008. Optimization of conditions for galactooligosaccharide synthesis during lactose hydrolysis by b-galactosidase from Kluyveromyces lactis (Lactozym 3000 L HP G). Food Chem 107:258-264 

  67. Miller MA, Parkman HP, Urbain JLC, Brown KL, Donahue DJ, Knight LC, Maurer AH, Fisher RS. 1997. Comparison of scintigraphy and lactulose breath test transit. Dig Dis Sci 42:10-18 

  68. Minami Y, Yazawa K, Tamura Z, Tanak T, Yamamoto T. 1983. Selectivity of utilization of galalctosyl-oligosaccharides by bifidobacteria. Chem Pharmac Bull 31:1688-1691 

  69. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. 2006. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of ages. Arch Dis Childhood 91:814-819 

  70. Mountzouris KC, Gilmour SG, Grandison A, Rastall RA. 1998. Modelling of oligodextran production in an ultrafiltration stirred cell membrane reactor. Enzyme Microbial Technol 24:75-85 

  71. Nadal ES. 2008. Application of prebiotics and probiotics in meat products. In Technological Strategies for Functional Meat Products Development, Kerala, India, Transworld Research Network. pp.117-137 

  72. Nilsson KGI. 1988. Enzymatic synthesis of oligosaccharides. Trends in Biotechnol 6:256-264 

  73. Nooshkama M, Madadlou A. 2016. Maillard conjugation of lactulose with potentially bioactive peptides. Food Chem 192:831-836 

  74. Ohkusa T, Ozaki Y, Sato C, Mikuni K, Ikeda H. 1995. Longterm ingestion of lactosucrose increases Bifidobacterium sp. in human fecal flora. Digestion 56:415-420 

  75. Okazaki M, Fujikawa S, Matsumoto N. 1990. Effect of xylooligosaccharide on the growth of bifidobacteria. Bifidobacteria Microflora 9:77-86 

  76. Oku T, Nakamura S. 2003. Comparison of digestibility and breath hydrogen gas excretion of fructo-oligosaccharides, galactosyl-sucrose and isomlto-oligosaccharide in health human subjects. Eu J Clin Nutr 57:1150-1156 

  77. Oliveira RP, Casazza AA, Aliakbarian B, Perego P, Converti A, Oliveira MN. 2013. Influence of fructooligosaccharides on the fermentation profile and viable counts in a symbiotic low fat milk. Braz J Microbiol 44:431-434 

  78. Ouwehand AC, Derrien M, de Vos W, Tiihonen K, Rautonen N. 2005. Prebiotics and other microbial substrates for gut functionality. Curr Opinion Biotechnol 16:212-217 

  79. Ozcelik MF, Pekmezci S, Altinli E, Eroglu C, Goksel S, Goksoy E. 1997. Lactulose to prevent translocation in biliary obstruction. Dig Surgery 14:267-271 

  80. Pain JA, Cahill Cj, Gilbert JM, Johnson CD, Trapnell JE, Bailey ME. 1991. Prevention of postoperative dysfuction in patients with obstructive jaundice: a multicentre study of bile slats and lactulose. Bri J Surgery 78:467-469 

  81. Palframan RJ, Gibson Gr, Rastall RA. 2002. Effect of pH and dose on the growth of gut bacteria on prebiotic carbohydrates in vitro. Anaerbe 8:287-292 

  82. Panesar PS, Kumari S. 2011. Lactulose: production, purification and potential applications. Biotechnol Adv 29:940-948 

  83. Petuely F. 1958. Der Bifidofaktor. Deutsche Mediziniche Wochenschrift 82:1957-1960 

  84. Piirainen L, Kekkonen RA, Kajander K, Ahlroos T, Tynkkynen S, Nevala R, Korpela R. 2008. In school-aged children a combination of galacto-oligosaccharides and Lactobacillus GG increases bifidobacteria more than Lactobacillus GG on its own. Ann Nutr Metab 52:204-208 

  85. Pineiro M, Asp NG, Reid G, Macfarlane S, Morelli L, Brunser O, Kieran T. 2008. FAO technical meeting on prebiotics. J Clin Gastroenterol 42:S156-S159 

  86. Playne MJ, Crittenden R. 1996. Commercially available oligosaccharides. Bull of Intl Dairy Fed 313:19-22 

  87. Prosky L. 1999. Inulin and oligofructose are part of the fiber complex. J AOAC Intl 82:223-226 

  88. Rada V, Duskova D, Marounek M, Petr J. 2001. Enrichment of Bifidobacteria in the hen caeca by dietary inulin. Folia Microbiol 46:73-75 

  89. Rafter J, Bennett M, Cadermi G, Clune Y, Hughes R, Karlsson PC, Klinder A, O'Riordan M, O'Sullivan GC, Pool-Zobel B, Rechkemmer G, Roller M, Rowland I, Salvadori M, Thijs H, Van Loo J, Watzl B, Collins JK. 2007. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr 85:488-496 

  90. Reid G, Sanders ME, Gaskins HR, Gibson GR, Mercenier A, Rastall R, Roberfroid M, Rowland I, Cherbut C, Klaenhammer TR. 2003. New scientific programs for probiotics and prebiotics. J Clin Gastroenerol 37:105-118 

  91. Rhoades J, Manderson K, Wells A, Hotchkiss Jr AT, Gibson GR, Formentin K, Beer M, Rastall RA. 2008. Oligosaccharidemediated inhibition of the adhesion of pathogenic Escherichia coli strains to human gut epithelial cells in vitro. J Food Protection 71:2272-2277 

  92. Roberfroid M, Gibson GR, Delzenne N. 1993. The biochemistry of oligofructose, a nondigestible fiber: An approach to calculate its caloric value. Nutr Rev 51:137-146 

  93. Roberfroid MB. 1997. Health benefits of non-digestible oligosaccharides, in Dietary Fiber in Health and Disease, New York, Plenum Press. pp.211-219 

  94. Roberfroid MB, Van Loo J, Gibson GR. 1998. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 128:11-19 

  95. Rowland IR, Rumney CJ, Coutts JT, Lievense L. 1998. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen induced aberrant crypt foci in rats. Carcinogenesis 2:281-285 

  96. Rozan P, Nejdi A, Hidalgo S, Bisson JF, Desor D, Messaoudi M. 2008. Effects of lifelong intervention with an oligofructoseenriched inulin in rats on general health and lifespan. Br J Nutr 100:1192-1199 

  97. Rycroft CE, Jones MR, Gibson GR, Rastall RA. 2001a. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 91:878-887 

  98. Rycroft CE, Jones MR, Gibson GR, Rastall RA. 2001b. Fermentation properties of gentio-oligosaccharides. Lett Appl Microbiol 32:156-161 

  99. Sako T, Matsumoto K, Tanaka R. 1999. Recent progress on research and applications of non-digestible galacto-oligosaccharides. Intl Dairy J 9:69-80 

  100. Sarbini SR, Kolida S, Gibson GR, Rastall RA. 2012. In vitro fermentation of commercial ${\alpha}$ -gluco-oligosaccharide by faecal microbiota from lean and obese human subjects. Brit J Nutr 109:1980-1989 

  101. Scholtens PA, Alliet P, Raes M, Alles MS, Kroes H, Boehm G, Knippels LM, Knol J, Vandenplas Y. 2008. Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and longchain fructo-oligosaccharides. J Nutr 138:1141-1147 

  102. Scholz-Ahrens KF, Acil Y, Schrezenmeir J. 2002. Effect of loigofructose or dietary calcium on repeated calcium and phosphorus balances, bone mineralization and trabecular structure in ovariectomied rats. Brit J Nutr 88:365-377 

  103. Scholz-Ahrens KE, Ade P, Marten B, Weber P, Timm W, Acil Y, Gluer CC, Schrezenmeir J. 2007. Prebiotics, probiotics, and synbiotics affect minaral absorption, bone mineral content, and bone structure. J Nutr 137:838S-846S 

  104. Schumann C. 1997. Die immunologischen effekte der Lactulose. Notabene Medicine 27:288-290 

  105. Seki N, Hamano H, Ilyama Y, Asano Y, Kokubo S, Yamauchi K, Tamura Y, Uenishi K, Kudou H. 2007. Effect of lactulose on calcium and magnesium absorption: a study using stable istotopes in adult men. J Nutr Sci Vitaminol 53:5-12 

  106. Seki N, Saito H. 2012. Lactose as a source for lactulose and other functional lactose derivatives. Intl Dairy J 22:110-115 

  107. Shin MY, Kwun IS. 2016. Vitamin D: hormone-like nutrient. J Nutr and Health 49:1-7 

  108. Shoaib M, Shehzad A, Omar M, Rakha A, Raza H, Sharif HR, Shakeel A, Ansaria A, Niazi S. 2016. Inulin: Properties, health benefits and food applications. Carbohydrate Polymers 147:444-454 

  109. Smits-Van Prooije AE, De Groot AP, Dreef-Van Der Meulen HC, Sinkeldam EJ. 1990. Chronic toxicity and carcinogenicity study of isomalt in rats and mice. Food Chem Toxicol 28: 243-251 

  110. Sung HY, Jeoung HJ, Choi YS, Cho SH, Yun JW. 2004. Effect of chicory inulin and oligosaccharises on lipid metabolism in rats fed a high-cholesterol diet. J Korean Soc Food Sci Nutr 33:305-310 

  111. Taniguchi Y, Mizote A, Kohno K, Iwaki K, Oku K, Chaen H, Fukuda S. 2007. Effects of dieatry lactosucrose(4G- ${\beta}$ -D-galactosylsucrose) on IgE response in mice. Biosci Biotech Biochem 71:2766-2773 

  112. Terada A, Hara H, Katapka M, Mitsuoka T. 1992. Effect of lactulose on the composition and metabolic activity of the human faecal flora. Micobial Ecol Health Dis 5:43-50 

  113. Teramoto F, Rokutan K, Sugamo Y, Oku K, Kishino E, Fujita K, Kshi K, Fukunaga M, Morrita T. 2006. Long-term administration of 4G- ${\beta}$ -D-galactosylsucrose (lactosucrose) enhances intestinal calcium absorption in young women: a randomized, placebo-controlled 96-wk study. J Nutr Sci Vitaminol 52: 337-346 

  114. Teuri U, Korpela R. 1998. Galacto-oligosaccharides relieve constipation in elderly people. Annals Nutr Metabolism 42:319-327 

  115. Tomoda T, Nakano Y, Kageyama T. 1988. Intestinal Candida overgrowth and Candida infection in patients with leukemia: effect of Bifidobacterium administration. Bifidobacteria Microflora 7:71-74 

  116. Tomomatsu H. 1994. Health effects of oligosaccharides. Ingestion of oligosaccharides increases the bifidobacteria population in the colon, which in turn contributes to human health in many ways. Food Technol 48:61-65 

  117. Touhy KM, Ziemer CJ, Klinder A. 2002. A human volunteer study to determine the prebiotic effects of lactulose powder on human colonic microbiota. Microbial Ecol Health Dis 14:165-173 

  118. Trautwein EA, Rieckhoff D, Erbersdobler HF. 1998. Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile in hamsters. J Nutr 128: 1937-1943 

  119. Tuohy KM, Finlay RK, Wynne AG, Gibsn GR. 2001. A human volunteer study on the prebiotic effects of HP-inulin-faecal bacteria enumerated using flourescent in situ hybridisation (FISH). Anaerobe 7:113-118 

  120. Turnbaugh PJ, Ley Re, Mahowald MA, Magrini V, Mardis Er, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027-1131 

  121. Van Dokkum W. 1995. Tolerantie voor galacto-oligosaccharide bij de mens. TNO Nutr Food Res Institute, The Netherlands, Confidential report 

  122. Van Laere KM, Hartemink R, Bosveld M, Schols HA, Voragen AG. 2000. Fermentation of plant cell wall derived poly-saccharides and their corresponding oligosaccharides by intestinal bacteria. J Agric Food Chem 48:1644-1652 

  123. Van Loo J, Coussement P, De Leenheer L, Hoebregs H, Smits G. 1995. On the presence of inulin and oligofructose as natural ingredients in the Western diet. Critical Rev Food Sci Nutr 35:525-552 

  124. Venema K. 2012. Intestinal fermentation of lactose and prebiotic lactose derivatives, including human milk oligosaccharides. Intl Dairy J 22:123-140 

  125. Verghese M, Walker LT, Shackelford L, Chawan CB. 2005. Inhibitory effects of nondigestible carbohydrates of different chain length on azoxymethane-induced aberrant crypt foci in Fisher 344 rats. Nutr Res 25:859-868 

  126. Voragen AGJ. 1998. Technological aspects of functional foodrelated carbohydrates. Trends Food Sci Technol 9:328-335 

  127. Waalkens-Berendsen DH, Koeter HBWM, Schluter G, Renhof M. 1989. Developmental toxicity of isomalt in rats. Food Chem Toxicol 27:631-637 

  128. Waalkens-Berendsen DH, Koeter HBWM, Sinkeldam EJ. 1990a. Multigeneration reproduction study of isomalt in rats. Food Chem Toxicol 28:11-19 

  129. Waalkens-Berendsen DH, Koeter HBWM, van Marwijk MW. 1990b. Embryotoxicity/teratogenicity of isomalt in rats and rabbits. Food Chem Toxicol 28:1-9 

  130. Wada L, Watabe J, Mizutani J, Tomoda M, Suzuki H, Saitoh Y. 1992. Effects of soybean oligosaccharides in a beverage on human fecal flora and metabolites. J Agric Chem Soc Japan 66:127-135 

  131. Wang HF, Lim PS, Kao MD, Chan EC. Lin LC, Wang NP. 2001. Use of isomalto-oligosaccharide in the treatment of lipid profiles and constipation in hemodialysis patients. J Renal Nutr 11:73-79 

  132. Wang SL, Liu CP, Liang TW. 2012. Fermented and enzymatic production of chitin/chitosan oligosaccharides by extracellular chitinases from Bacillus cereus TKU027. Carbohydrate Polymers 90:1305-1313 

  133. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV. 2008. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455:1109-1113 

  134. Wiedmann M, Jager M. 1997. Synergistic sweeteners. Food Ingredients and Anal Intl 19:51-56 

  135. Wijnands MVW, Schoterman HC, Bruijntjes JB, Hollanders VM, Woutersen RA. 2001. Effect of dietary galactooligosaccharides (GOS) on azoxymethane-induced colorectal cancer in Fischer 344 Rats. Carcinogenesis 22:127-132 

  136. Yamahita K, Kobata A. 1974. Oligosaccharides of human milk. Arch Biochem Biophysics 161:164-170 

  137. Yanahira S, Morita M, Aoe S, Suguri T, Takada Y, Miura S, Nakajima I. 1997. Effects of lactiol-oligosaccharides on calcium and magnesium absorption in rats. J Nutr Sci Vitaminol 43:123-132 

  138. Yin L, Laevsky G, Giardina C. 2001. Butyrate suppression of colonocyte NF-kappa B acitivation and cellular proteasome activity. J Biol Chem 276:44641-44646 

  139. Zhang M, Cai S, Ma JW. 2015. Evaluation of cardio-protective effect of soybean oligosaccharides. Gene 555:329-334 

  140. Zokaee F, Kaghazchi T, Zare A, Soleimani M. 2002. Isomerization of lactose to lactulose-study and comparison of three catalytic systems. Process Biochem 47:629-635 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로